Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Eileen Dimond"'
Autor:
Oukseub Lee, Latifa A. Bazzi, Yanfei Xu, Erik Pearson, Minhua Wang, Omid Hosseini, Azza M. Akasha, Jennifer Nam Choi, Scott Karlan, Melissa Pilewskie, Masha Kocherginsky, Kelly Benante, Thomas Helland, Gunnar Mellgren, Eileen Dimond, Marjorie Perloff, Brandy M. Heckman-Stoddard, Seema A. Khan
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116105- (2024)
Breast cancer prevention only requires local exposure of the breast to active drug. However, oral preventive agents entail systemic exposure, causing adverse effects that limit acceptance by high-risk women. Drug-delivery through the breast skin is a
Externí odkaz:
https://doaj.org/article/866b000bd0524b18baec1ef3a47518c6
Autor:
Lori M. Minasian, MD, Eileen Dimond, RN, MS, Myrtle Davis, DVM, PhD, ATS, Bishow Adhikari, PhD, Richard Fagerstrom, PhD, Carol Fabian, MD, Justin Floyd, DO, Joseph M. Unger, PhD, MS, Pamela S. Douglas, MD, Karen M. Mustian, PhD, MPH, Eric J. Chow, MD, MPH, Steven Lipshultz, MD, W. Gregory Hundley, MD, Saro H. Armenian, DO, MPH, Bonnie Ky, MD, MSCE
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outco
Externí odkaz:
https://doaj.org/article/c9974a1a47d043b78c7cfd5e8ff19334
Autor:
Yi Zeng, Anna-Barbara Moscicki, Vikrant V. Sahasrabuddhe, Francisco Garcia, Heide Woo, Chiu-Hsieh Hsu, Eva Szabo, Eileen Dimond, Susan Vanzzini, Angelica Mondragon, Valerie Butler, Hillary DeRose, H.-H. Sherry Chow
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Human papillomavirus (HPV) vaccines are indicated for the prevention of cancers and genital warts caused by vaccine-covered HPV types. Although the standard regimen requires a two or three-dose vaccine series, there is emerging da
Externí odkaz:
https://doaj.org/article/5200619456294d669da235425ea52582
Autor:
Anne E. O'Shea, Guy T. Clifton, Na Qiao, Brandy M. Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E. Garber, Alexander Husband, Ricardo Pastorello, J. Jack Lee, Mike Hernandez, Diane D. Liu, Lana A. Vornik, Powel H. Brown, Gheath Alatrash, George E. Peoples, Elizabeth A. Mittendorf
Publikováno v:
Cancer Prevention Research. :OF1-OF9
NeuVax is a vaccine comprised of the HER2-derived MHC class I peptide E75 (nelipepimut-S, NPS) combined with GM-CSF. We completed a randomized trial of preoperative vaccination with NeuVax versus GM-CSF alone in patients with ductal carcinoma in situ
Autor:
Meghna S. Trivedi, Nadir Arber, Eitan Friedman, Judy E. Garber, Kevin Holcomb, Neil S. Horowitz, Jason D. Wright, J. Jack Lee, Lana A. Vornik, Saba Abutaseh, Tawana Castile, Edward R. Sauter, Eileen Dimond, Brandy M. Heckman-Stoddard, Margaret House, Goli Samimi, Powel H. Brown, Katherine D. Crew
Publikováno v:
Cancer Prevention Research. 15:721-726
Female carriers of pathogenic/likely pathogenic (P/LP) BRCA1/2 variants are at increased risk of developing breast and ovarian cancer. Currently, the only effective strategy for ovarian cancer risk reduction is risk-reducing bilateral salpingo-oophor
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
NeuVax is a vaccine comprised of the HER2-derived MHC class I peptide E75 (nelipepimut-S, NPS) combined with GM-CSF. We completed a randomized trial of preoperative vaccination with NeuVax versus GM-CSF alone in patients with ductal carcinoma in situ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f651670fa931553a9dd3bc374ba8183
https://doi.org/10.1158/1940-6207.c.6642622.v1
https://doi.org/10.1158/1940-6207.c.6642622.v1
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
Supplementary Table S5: HER2 expression in biopsy and resection specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1943aef419ca844e93810d26a9c95bd6
https://doi.org/10.1158/1940-6207.22806877.v1
https://doi.org/10.1158/1940-6207.22806877.v1
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
Supplementary Fig. S1: Nelipepimut-S (NPS)-specific cytotoxic T lymphocyte (CTL) responses in patients receiving NeuVax with corresponding HER2 changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e59b72fc42e69fd9132efc0311f9f74
https://doi.org/10.1158/1940-6207.22806895.v1
https://doi.org/10.1158/1940-6207.22806895.v1
Autor:
Powel H. Brown, Marjorie Perloff, Brandy M. Heckman-Stoddard, Eileen Dimond, Seema A. Khan, Lana A. Vornik, Diane Weber, Carrie Mays, Valerie Sepeda, Alejandro Contreras, Miguel Muzzio, Mike Hernandez, Diane D. Liu, J. Jack Lee, Anisha B. Patel, Parijatham S. Thomas
Supplementary Table from Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064514fb8344b0af29e094446fbc0a6e
https://doi.org/10.1158/1940-6207.22533313.v1
https://doi.org/10.1158/1940-6207.22533313.v1
Autor:
Powel H. Brown, Marjorie Perloff, Brandy M. Heckman-Stoddard, Eileen Dimond, Seema A. Khan, Lana A. Vornik, Diane Weber, Carrie Mays, Valerie Sepeda, Alejandro Contreras, Miguel Muzzio, Mike Hernandez, Diane D. Liu, J. Jack Lee, Anisha B. Patel, Parijatham S. Thomas
Agents that can reduce the incidence of hormone receptor negative breast cancer are currently lacking. Rexinoids such as bexarotene significantly reduced mammary tumor development in preclinical mouse models. Oral bexarotene in BRCA mutation carriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d02dacc3995a20d4b0470d679d3c74
https://doi.org/10.1158/1940-6207.c.6547021.v1
https://doi.org/10.1158/1940-6207.c.6547021.v1